Tough Times Ahead for Anatomic Pathology as Group Revenue Declines and Pathologists’ Incomes Drop Due to Payer Price Cuts, Narrow Networks, and Claims Denials

Many pathology groups report shrinking revenue, yet some innovative pathology groups continue to grow through savvy pricing and by adding value to payers and physicians Times are tough for anatomic pathologists in private practice. Medicare programs and private payers regularly slash prices for both technical component and professional component services. In addition, the growing number of narrow networks means that pathology groups find themselves excluded from access to an ever-larger...

In Fixing Physician Medicare Pay, Congress Enacts Yet Another Cut in Clinical Laboratory Test Fee Schedule

A part of this legislation, the grandfather clause on Technical Component (TC) anatomic pathology services was extended through June 1, 2012. Last Friday, clinical laboratories got bad news about new cuts to the Medicare Part B medical laboratory test fee schedule. Congress voted on a temporary funding fix to keep Medicare physician fees at current levels for 10 more months and a reduction in lab test fees was one source of the money that Congress used to fund this bill. Pathologists and...

American Pathology Partners Announces Acquisition of Laboratory Assets of Palm Beach Pathology

This is APP’s third acquisition of an anatomic pathology laboratory since 2008 Earlier today, it was announced that American Pathology Partners had acquired the anatomic pathology laboratory assets of Palm Beach Pathology, the private pathology practice located in West Palm Beach, Florida. No purchase price was disclosed. Consistent with its business model, American Pathology Partners (APP) purchased the pathology laboratory owned and operated by Palm Beach Pathology, along with its staff and...

Medicare Laboratory Competitive Bid Repeal Passed by Senate Yesterday

Yesterday was big news for the lab industry as Senate passed the “The Medicare Improvement for Patients and Providers Act of 2008″ (HR 6331).” This bill includes repeal of the Medicare Laboratory Competitive Bidding Demonstration Project. Because the House passed this bill last month, it means the bill now moves to the President for his signature or veto. Also included in this Medicare funding bill for 2008 are a reversal of the 10.6% cut in Medicare physician reimbursement...
;